4D Molecular Therapeutics, Inc.
FDMT
$10.45
$0.111.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.92% | 31.99% | 4.04% | -8.78% | -24.35% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 38.10% | 43.27% | -27.31% | -9.59% | 10.68% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -1.88% | 32.25% | 3.00% | -8.80% | -23.54% |
|
|
|||||
| Total Current Assets | -1.88% | 32.25% | 3.00% | -8.80% | -23.54% |
| Net Property, Plant & Equipment | -6.26% | -5.85% | -5.64% | -5.02% | -3.67% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.29% | -2.05% | -0.11% | 33.32% | 65.29% |
| Total Assets | -9.49% | 33.66% | -10.48% | -8.16% | -7.97% |
|
|
|||||
| Total Accounts Payable | 31.66% | 62.60% | -21.11% | 109.59% | -5.36% |
| Total Accrued Expenses | -14.91% | 11.10% | 26.05% | 18.43% | -14.13% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -1.90% | -1.81% | -0.45% | 0.74% | 0.75% |
| Total Finance Division Other Current Liabilities | 0.00% | 0.00% | -66.23% | 23.09% | 236.96% |
| Total Other Current Liabilities | 0.00% | 0.00% | -66.23% | 23.09% | 236.96% |
| Total Current Liabilities | -1.32% | 18.54% | 7.01% | 28.92% | -7.72% |
|
|
|||||
| Total Current Liabilities | -1.32% | 18.54% | 7.01% | 28.92% | -7.72% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.88% | -4.51% | -4.54% | -4.50% | -4.19% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 110.80% | -6.27% | 85.43% | -23.47% | -43.80% |
| Total Liabilities | 0.04% | 11.00% | 4.27% | 14.65% | -7.58% |
|
|
|||||
| Common Stock & APIC | 1.30% | 10.62% | 0.42% | 0.53% | 0.64% |
| Retained Earnings | -9.60% | 2.64% | -8.38% | -8.76% | -8.33% |
| Treasury Stock & Other | -124.76% | 8.35% | 99.11% | 1.51% | 44.98% |
| Total Common Equity | -10.65% | 37.04% | -12.33% | -10.40% | -8.01% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.65% | 37.04% | -12.33% | -10.40% | -8.01% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -10.65% | 37.04% | -12.33% | -10.40% | -8.01% |
|
|
|||||